Catherine Loustalot
Publications by Year
Research Areas
Breast Cancer Treatment Studies, BRCA gene mutations in cancer, Cancer survivorship and care, HER2/EGFR in Cancer Research, Breast Lesions and Carcinomas
Most-Cited Works
- → Quality of life after mastectomy with or without immediate breast reconstruction(2017)132 cited
- → Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes(2012)110 cited
- → Pathologic Complete Response to Trastuzumab-Based Neoadjuvant Therapy Is Related to the Level of HER-2 Amplification(2007)106 cited
- → Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer(2017)81 cited
- → β3-Adrenoceptor Is the Predominant β-Adrenoceptor Subtype in Human Myometrium and Its Expression Is Up-Regulated in Pregnancy(2005)68 cited
- → Functional, biochemical and molecular biological evidence for a possible β3‐adrenoceptor in human near‐term myometrium(2000)54 cited
- → Time to Deterioration in Quality of Life Score as a Modality of Longitudinal Analysis in Patients with Breast Cancer(2011)52 cited
- → Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?(2007)48 cited
- → The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?(2016)46 cited
- → Impact of sentinel node biopsy on long-term quality of life in breast cancer patients(2013)45 cited